Imprimis launches low-cost Daraprim alternative
October 26, 2015Sales and Marketing Daraprim, Imprimis, Martin Skhreli, turing
Imprimis Pharmaceuticals has announced that it has made available a customisable compounded formulation of pyrimethamine and leucovorin accessible for physicians …
CEO prepares for day of reckoning over Valeant fraud allegations
October 26, 2015Sales and Marketing J. Michael Pearson, Valeant
Troubled Valeant Pharmaceuticals last week announced strong third quarter revenues, reporting a 36% increase in revenues to $172 million, but …
Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize
October 26, 2015Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize
Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.The award is in recognition …
FDA backs AZ gout drug despite safety concerns
October 26, 2015Sales and Marketing AstraZeneca, Zurampic, gout, lesinurad
FDA reviewers have recommended approving AstraZeneca’s new gout therapy Zurampic, which the company purchased in a $1.3 billion buyout, despite …
Shire reports 7% product sales growth, continues Baxalta pursuit
October 23, 2015Sales and Marketing Baxalta, Shire
Shire has exceeded market expectations as it reported an 11% rise in Q3 earnings on Friday, driven by product sales, …
Novartis’ Cosentyx gets European approval for two conditions
October 23, 2015Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis
The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …
Amgen skin cancer drug gets European approval
October 23, 2015Research and Development Amgen, Imlygic, melanoma, skin cancer
Amgen’s Imlygic (talimogene laherparepvec) has been approved by the scientific committee of the European Medicines Agency (EMA) for the treatment of adults …
New general manager for Roche UK
October 23, 2015Medical Communications
Richard Erwin has joined Roche as the new UK General Manager.Richard’s passion for driving sustainable change and championing patient needs …
FDA warns AbbVie hep C drugs linked to serious liver damage
October 23, 2015Medical Communications AbbVie
AbbVie stocks tumbled 14% yesterday after the FDA warned that two of the company’s hepatitis C drugs could cause serious …
OLS backs UK to become global digital health leader
October 23, 2015Medical Communications Big Data, Office for Life Sciences, digital health, health analytics, mhealth, patient records, telehealth, telehealthcare
The UK market has the potential to lead the world in digital health – if certain barriers are overcome – …
COMPANY PROFILE: The secrets of that Merck rebrand
October 23, 2015Medical Communications, Sales and Marketing Merck, branding, communications, corporate logo, reputation
Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …
Gilead presents Phase III results for Genvoya in HIV
October 22, 2015Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV
Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …
NICE recommends four treatments for arthritis in children
October 22, 2015Medical Communications, Research and Development NICE, arthritis, jia
UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
NICE recommends four treatments for arthritis in children
October 22, 2015Medical Communications, Research and Development NICE, arthritis, jia
UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
UK and China sign £2 billion in healthcare trade and investment deals
October 22, 2015Research and Development
More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …
Physicians Interactive acquires Univadis portal
October 22, 2015Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis
Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …
Executive vice president Tony Kingsley leaves Biogen
October 22, 2015Biogen, John Cox, Tony Kingsley
Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …
Roche buoyed by 6% sales growth
October 22, 2015Sales and Marketing Roche, financial results
Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …
World’s largest clinical trial of aspirin in cancer launches in UK
October 22, 2015Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III
The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
Revenues up at Biogen – but job losses planned
October 22, 2015Biogen, financial results, job losses, redundancies
Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
